Vaccine cancer risk
Dr. John CampbellPublished on September 30, 2025
Summary authored by editor@wellifi.com
TLDR Summary
Recent studies indicate a concerning increase in cancer rates among individuals vaccinated against COVID-19, with specific increases in lung, prostate, and thyroid cancers. These findings prompt questions about vaccine safety and the need for ongoing public discourse.
Key Points
- COVID-19 vaccination linked to a 27% overall increase in cancer rates.
- Significant increases in specific cancers: lung (53%), prostate (69%), thyroid (35%), gastric (34%), breast (20%), colorectal (28%).
- Study based on over 8 million participants from South Korea’s health database.
- Higher cancer risks associated with DNA vaccines compared to mRNA vaccines.
- Calls for public awareness and action regarding vaccine safety and government control.
Concerns About Cancer Risks Associated with COVID-19 Vaccination
In a recent talk, oncologist Professor Angus Algles raised alarming concerns regarding potential cancer risks associated with COVID-19 vaccinations. Despite initial skepticism about these claims, new evidence from studies, notably a large-scale study from South Korea, suggests a significant increase in cancer rates among vaccinated individuals.
Key Findings from Recent Studies
Recent data indicate that the overall cancer rate among vaccinated individuals is 27% higher than that of their unvaccinated counterparts. The study highlights specific increases in various cancer types:
- Lung Cancer: 53% increase
- Prostate Cancer: 69% increase
- Thyroid Cancer: 35% increase
- Gastric Cancer: 34% increase
- Breast Cancer: 20% increase
- Colorectal Cancer: 28% increase
This data comes from a comprehensive cohort study that included over 8 million participants, making it one of the most extensive examinations of this issue to date.
Understanding the Study
The study was designed to assess the cumulative incidence of cancers one year after COVID-19 vaccination. Researchers utilized data from the Korean National Health Insurance Database to compare the health outcomes of vaccinated and unvaccinated groups. The findings were statistically significant, with a p-value of 0.001, suggesting a very low likelihood that these results occurred by chance.
Specific Cancer Risks
The study analyzed various types of cancer and found notable differences based on vaccine type and demographics:
- DNA vaccines (e.g., Johnson & Johnson, AstraZeneca) were associated with increased risks for thyroid, gastric, colorectal, lung, and prostate cancers.
- mRNA vaccines were linked to thyroid, colorectal, lung, and breast cancers.
- Individuals under 65 exhibited higher risks for thyroid and breast cancers, while older adults were more susceptible to prostate cancer.
- Those receiving booster doses faced heightened risks for gastric and pancreatic cancers.
The implications of these findings raise questions about vaccine safety and the need for further investigation into potential long-term effects.
Additional Health Concerns
In addition to cancer risks, the video highlights other side effects associated with COVID-19 vaccinations, including:
- Blood clotting disorders
- Postural orthostatic tachycardia syndrome
- Neurological disorders such as Guillain-Barré syndrome and Bell's palsy
- Reproductive health issues
- Long COVID-like symptoms
These concerns, coupled with the cancer risks, suggest a need for ongoing monitoring and reassessment of vaccine safety.
Calls for Action
The discussion culminates in a call for public awareness and action. Professor Algles urges individuals to explore the research and consider signing a government petition against the introduction of digital identity cards, which he argues could lead to increased government control over personal choices.
Conclusion
The implications of recent studies on COVID-19 vaccination and cancer risks are significant and warrant further investigation. As the medical community grapples with these findings, it is crucial for individuals to stay informed and engage in discussions surrounding vaccine safety and public health policies.